$DNMR
Danimer Scientific, Inc.

2023 Q3 Form 10-Q Financial Statement

#000095017023039907 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $10.95M $12.87M $12.70M
YoY Change 4.79% 1.28% -12.22%
Cost Of Revenue $18.69M $19.43M $13.06M
YoY Change 28.84% 48.82% 4.8%
Gross Profit -$7.737M -$6.568M -$355.0K
YoY Change 90.8% 1750.14% -117.65%
Gross Profit Margin -70.67% -51.05% -2.79%
Selling, General & Admin $16.56M $16.84M $22.69M
YoY Change -14.72% -25.76% 18.92%
% of Gross Profit
Research & Development $6.883M $7.709M $8.287M
YoY Change -13.39% -6.97% 108.48%
% of Gross Profit
Depreciation & Amortization $7.260M $7.173M $4.329M
YoY Change 58.38% 65.7% 95.79%
% of Gross Profit
Operating Expenses $23.44M $24.55M $31.76M
YoY Change -14.33% -22.7% 37.78%
Operating Profit -$31.24M -$31.12M -$32.12M
YoY Change -67.08% -3.11% 52.4%
Interest Expense -$8.450M -$8.079M $1.360M
YoY Change -1628.03% -694.04% 512.61%
% of Operating Profit
Other Income/Expense, Net -$8.452M -$8.181M $75.00K
YoY Change 4002.91% -11008.0% -99.88%
Pretax Income -$39.69M -$39.30M -$30.69M
YoY Change -58.27% 28.08% -178.18%
Income Tax $500.0K -$100.0K -$240.0K
% Of Pretax Income
Net Earnings -$40.16M -$39.24M -$30.45M
YoY Change -57.67% 28.89% -177.57%
Net Earnings / Revenue -366.82% -305.02% -239.67%
Basic Earnings Per Share -$0.39 -$0.38 -$0.30
Diluted Earnings Per Share -$0.39 -$0.38 -$301.3K
COMMON SHARES
Basic Shares Outstanding 102.0M 101.9M 101.1M
Diluted Shares Outstanding 102.0M 101.9M 101.0M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $77.40M $90.77M $140.4M
YoY Change -21.92% -35.34% -66.28%
Cash & Equivalents $77.39M $90.77M $140.4M
Short-Term Investments
Other Short-Term Assets $4.800M $5.441M $5.394M
YoY Change -5.51% 0.87% 16.98%
Inventory $26.69M $29.87M $32.73M
Prepaid Expenses $4.754M $5.441M
Receivables $12.42M $13.00M $22.12M
Other Receivables $700.0K $1.481M $1.408M
Total Short-Term Assets $127.1M $145.4M $202.0M
YoY Change -21.85% -28.05% -55.27%
LONG-TERM ASSETS
Property, Plant & Equipment $449.8M $454.1M $428.0M
YoY Change 2.96% 6.1% 167.54%
Goodwill
YoY Change
Intangibles $78.66M $79.33M
YoY Change -3.47%
Long-Term Investments
YoY Change
Other Assets $346.0K $344.0K $2.090M
YoY Change 52.42% -83.54% 2843.66%
Total Long-Term Assets $593.9M $598.9M $588.7M
YoY Change 4.05% 1.73% 203.6%
TOTAL ASSETS
Total Short-Term Assets $127.1M $145.4M $202.0M
Total Long-Term Assets $593.9M $598.9M $588.7M
Total Assets $721.0M $744.3M $790.7M
YoY Change -1.69% -5.88% 22.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.909M $3.558M $11.75M
YoY Change -9.6% -69.71% -38.07%
Accrued Expenses $5.899M $4.985M $13.26M
YoY Change -71.09% -62.41% 124.76%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.184M $1.847M $2.242M
YoY Change -21.12% -17.62% 573.27%
Total Short-Term Liabilities $14.77M $14.60M $30.61M
YoY Change -53.22% -52.3% 5.65%
LONG-TERM LIABILITIES
Long-Term Debt $378.7M $376.0M $262.0M
YoY Change 32.43% 43.49% 785.96%
Other Long-Term Liabilities $1.153M $1.083M $25.74M
YoY Change 79.88% -95.79% 4017.76%
Total Long-Term Liabilities $1.153M $1.083M $287.8M
YoY Change 79.88% -99.62% 852.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.77M $14.60M $30.61M
Total Long-Term Liabilities $1.153M $1.083M $287.8M
Total Liabilities $416.7M $414.0M $318.9M
YoY Change 21.96% 29.83% 129.3%
SHAREHOLDERS EQUITY
Retained Earnings -$414.7M -$374.5M
YoY Change 53.25%
Common Stock $10.00K $10.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $304.3M $330.3M $471.9M
YoY Change
Total Liabilities & Shareholders Equity $721.0M $744.3M $790.7M
YoY Change -1.69% -5.88% 22.48%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$40.16M -$39.24M -$30.45M
YoY Change -57.67% 28.89% -177.57%
Depreciation, Depletion And Amortization $7.260M $7.173M $4.329M
YoY Change 58.38% 65.7% 95.79%
Cash From Operating Activities -$10.18M -$15.29M -$19.79M
YoY Change -49.58% -22.75% 134.71%
INVESTING ACTIVITIES
Capital Expenditures $2.680M $6.641M -$49.95M
YoY Change -110.81% -113.3% 78.28%
Acquisitions
YoY Change
Other Investing Activities $20.00K $0.00 $55.00K
YoY Change -100.11% -100.0% -83.82%
Cash From Investing Activities -$2.660M -$6.641M -$49.89M
YoY Change -93.79% -86.69% 80.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -540.0K -6.510M -7.000K
YoY Change -102.35% 92900.0% -100.01%
NET CHANGE
Cash From Operating Activities -10.18M -15.29M -19.79M
Cash From Investing Activities -2.660M -6.641M -49.89M
Cash From Financing Activities -540.0K -6.510M -7.000K
Net Change In Cash -13.38M -28.44M -69.69M
YoY Change -66.59% -59.19% -168.56%
FREE CASH FLOW
Cash From Operating Activities -$10.18M -$15.29M -$19.79M
Capital Expenditures $2.680M $6.641M -$49.95M
Free Cash Flow -$12.86M -$21.93M $30.16M
YoY Change -379.99% -172.7% 54.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001779020
dei Amendment Flag
AmendmentFlag
false
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39280
dei Entity Registrant Name
EntityRegistrantName
DANIMER SCIENTIFIC, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1924518
dei Entity Address Address Line1
EntityAddressAddressLine1
140 Industrial Boulevard
dei Entity Address City Or Town
EntityAddressCityOrTown
Bainbridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
39817
dei City Area Code
CityAreaCode
229
dei Local Phone Number
LocalPhoneNumber
243-7075
dei Security12b Title
Security12bTitle
Class A Common stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
DNMR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
102035267
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90771000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62792000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12998000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
447000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17989000
CY2023Q2 us-gaap Other Receivables
OtherReceivables
1481000
CY2022Q4 us-gaap Other Receivables
OtherReceivables
1635000
CY2023Q2 us-gaap Inventory Net
InventoryNet
29866000
CY2022Q4 us-gaap Inventory Net
InventoryNet
32743000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5441000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5225000
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4818000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4687000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
145375000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
125071000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
454136000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
453949000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
79332000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
80941000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19153000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19028000
CY2023Q2 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31446000
CY2022Q4 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31446000
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
14467000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1609000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
344000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
226000
CY2023Q2 us-gaap Assets
Assets
744253000
CY2022Q4 us-gaap Assets
Assets
712270000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3558000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14977000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4985000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5001000
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
875000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
0
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3337000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3337000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1847000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1972000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
14602000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25287000
CY2023Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
245000
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
212000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22001000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22114000
CY2023Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
375994000
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
286398000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
44000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
200000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1083000
CY2023Q2 us-gaap Liabilities
Liabilities
413969000
CY2022Q4 us-gaap Liabilities
Liabilities
334658000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101938376
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101938376
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101804454
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101804454
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
10000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
704802000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
676250000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-374528000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-298648000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
330284000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
377612000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
744253000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
712270000
CY2023Q2 us-gaap Revenues
Revenues
12865000
CY2022Q2 us-gaap Revenues
Revenues
12703000
us-gaap Revenues
Revenues
24791000
us-gaap Revenues
Revenues
27446000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
19433000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
14934000
us-gaap Cost Of Revenue
CostOfRevenue
37642000
us-gaap Cost Of Revenue
CostOfRevenue
30999000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16844000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20975000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35543000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
43211000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7709000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8913000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14784000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16044000
CY2023Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-0
CY2022Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-1000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-170000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-1000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
43986000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
44823000
us-gaap Costs And Expenses
CostsAndExpenses
88139000
us-gaap Costs And Expenses
CostsAndExpenses
90255000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-31121000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-32120000
us-gaap Operating Income Loss
OperatingIncomeLoss
-63348000
us-gaap Operating Income Loss
OperatingIncomeLoss
-62809000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1083000
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2012000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
33000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7007000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-9162000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-652000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12548000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1644000
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-102000
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-102000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
75000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
84000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8181000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1435000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12683000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5447000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39302000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30685000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-76031000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-57362000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-61000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-240000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-151000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-531000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-39241000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-30445000
us-gaap Net Income Loss
NetIncomeLoss
-75880000
us-gaap Net Income Loss
NetIncomeLoss
-56831000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101938376
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101938376
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101047650
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101047650
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101917585
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101917585
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100888185
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100888185
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
330284000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
471855000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
330284000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
471855000
us-gaap Profit Loss
ProfitLoss
-75880000
us-gaap Profit Loss
ProfitLoss
-56831000
us-gaap Share Based Compensation
ShareBasedCompensation
27974000
us-gaap Share Based Compensation
ShareBasedCompensation
27983000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
14752000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
8588000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3485000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1152000
us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
948000
us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-826000
dnmr Inventory Reserves
InventoryReserves
464000
dnmr Inventory Reserves
InventoryReserves
597000
dnmr Amortization Of Right Of Use Assets And Lease Liability
AmortizationOfRightOfUseAssetsAndLeaseLiability
-237000
dnmr Amortization Of Right Of Use Assets And Lease Liability
AmortizationOfRightOfUseAssetsAndLeaseLiability
-173000
us-gaap Gain Loss On Disposition Of Other Financial Assets
GainLossOnDispositionOfOtherFinancialAssets
-170000
us-gaap Gain Loss On Disposition Of Other Financial Assets
GainLossOnDispositionOfOtherFinancialAssets
-1000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-155000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-531000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
33000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7007000
dnmr Contract With Customer Asset Reserves Recorded
ContractWithCustomerAssetReservesRecorded
0
dnmr Contract With Customer Asset Reserves Recorded
ContractWithCustomerAssetReservesRecorded
-1216000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1046000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-45000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5939000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2166000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-38000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-2692000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2383000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10838000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1130000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1434000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
959000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1540000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
120000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
5000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2377000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2693000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
600000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2220000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
636000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
875000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2077000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21151000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37393000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23041000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
108850000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
55000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23041000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-108809000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
130000000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
0
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
33295000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
279000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
11744000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
88000
dnmr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
129000
dnmr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
296000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
197000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
61000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
dnmr Payments Related To Warrants Costs
PaymentsRelatedToWarrantsCosts
0
dnmr Payments Related To Warrants Costs
PaymentsRelatedToWarrantsCosts
55000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
85029000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
71000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
40837000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-146131000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64401000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
286968000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105238000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
140837000
us-gaap Interest Paid Net
InterestPaidNet
9530000
us-gaap Interest Paid Net
InterestPaidNet
481000
us-gaap Operating Lease Payments
OperatingLeasePayments
1858000
us-gaap Operating Lease Payments
OperatingLeasePayments
1771000
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
2084000
dnmr Changes In Accounts Payable And Accrued Liabilities Related To Purchase Of Property Plant And Equipment
ChangesInAccountsPayableAndAccruedLiabilitiesRelatedToPurchaseOfPropertyPlantAndEquipment
-9658000
dnmr Changes In Accounts Payable And Accrued Liabilities Related To Purchase Of Property Plant And Equipment
ChangesInAccountsPayableAndAccruedLiabilitiesRelatedToPurchaseOfPropertyPlantAndEquipment
-11797000
us-gaap Notes Issued1
NotesIssued1
1346000
us-gaap Notes Issued1
NotesIssued1
2092000
dnmr Warrants Issued With Senior Secured Term Loan
WarrantsIssuedWithSeniorSecuredTermLoan
510000
dnmr Warrants Issued With Senior Secured Term Loan
WarrantsIssuedWithSeniorSecuredTermLoan
0
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2023Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
99700000
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
13746000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
19964000
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1538000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1524000
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
14582000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11255000
CY2023Q2 us-gaap Inventory Net
InventoryNet
29866000
CY2022Q4 us-gaap Inventory Net
InventoryNet
32743000
CY2023Q2 dnmr Finished Neat Pha Included In Finished Goods
FinishedNeatPhaIncludedInFinishedGoods
7900000
CY2022Q4 dnmr Finished Neat Pha Included In Finished Goods
FinishedNeatPhaIncludedInFinishedGoods
4900000
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
500000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
511339000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
498814000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
57203000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
44865000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
454136000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
453949000
CY2023Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7173000
CY2022Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
4328000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
14752000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
8588000
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
208128000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
198545000
CY2023Q2 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
14800000
CY2022Q4 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
14600000
CY2023Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
100000
CY2022Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2000000.0
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
200000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
3600000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P18Y
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
95090000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
94291000
CY2023Q2 dnmr Intangible Assets Not Yet Amortized
IntangibleAssetsNotYetAmortized
-2239000
CY2022Q4 dnmr Intangible Assets Not Yet Amortized
IntangibleAssetsNotYetAmortized
-1604000
CY2023Q2 dnmr Amortization Intangible Assets Gross
AmortizationIntangibleAssetsGross
92851000
CY2022Q4 dnmr Amortization Intangible Assets Gross
AmortizationIntangibleAssetsGross
92687000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-13350000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-8585000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-15758000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-13350000
CY2023Q2 dnmr Amortization Intangible Assets Net
AmortizationIntangibleAssetsNet
77093000
CY2022Q4 dnmr Amortization Intangible Assets Net
AmortizationIntangibleAssetsNet
79337000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
79332000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
80941000
CY2023Q2 dnmr Accrued Compensation And Related Liabilities
AccruedCompensationAndRelatedLiabilities
1557000
CY2022Q4 dnmr Accrued Compensation And Related Liabilities
AccruedCompensationAndRelatedLiabilities
1305000
CY2023Q2 dnmr Other Accrued Taxes
OtherAccruedTaxes
1159000
CY2022Q4 dnmr Other Accrued Taxes
OtherAccruedTaxes
669000
CY2023Q2 dnmr Construction In Progress Accrued Liabilities
ConstructionInProgressAccruedLiabilities
473000
CY2022Q4 dnmr Construction In Progress Accrued Liabilities
ConstructionInProgressAccruedLiabilities
1089000
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
455000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
134000
CY2023Q2 us-gaap Accrued Utilities Current And Noncurrent
AccruedUtilitiesCurrentAndNoncurrent
345000
CY2022Q4 us-gaap Accrued Utilities Current And Noncurrent
AccruedUtilitiesCurrentAndNoncurrent
415000
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
235000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
443000
CY2023Q2 dnmr Purchase Accrual
PurchaseAccrual
155000
CY2022Q4 dnmr Purchase Accrual
PurchaseAccrual
401000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
606000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
545000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4985000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5001000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0016
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0020
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-500000
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0078
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0093
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q2 dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
951000
CY2022Q2 dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
874000
dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
1745000
dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
1761000
CY2022Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P16Y
dnmr Incremental Borrowing Rate Percentage
IncrementalBorrowingRatePercentage
0.144
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
100000
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3914525
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3914525
us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2021-05-07
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
418007000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
298317000
CY2023Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
40166000
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
9947000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1847000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1972000
CY2023Q2 dnmr Long Term Debt Net Of Current Maturities And Debt Issuance Costs
LongTermDebtNetOfCurrentMaturitiesAndDebtIssuanceCosts
375994000
CY2022Q4 dnmr Long Term Debt Net Of Current Maturities And Debt Issuance Costs
LongTermDebtNetOfCurrentMaturitiesAndDebtIssuanceCosts
286398000
CY2021Q4 dnmr Convertible Senior Notes Due Year
ConvertibleSeniorNotesDueYear
2026
CY2021Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.79
CY2023Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
45000000
CY2023Q2 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31400000
CY2023Q2 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
1900000
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0674
CY2023Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0824
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1231000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
672000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
259000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
261121000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
130023000
CY2023Q2 dnmr Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
24701000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
418007000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101938376
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100760215
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101804454
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100687820
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0
CY2022Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
354646
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
133922
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
427041
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101938376
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101114861
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101938376
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101114861
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
125489
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
125489
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42163759
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40450929
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42163759
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40450929
CY2023Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1000000.0
CY2022Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
100000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1100000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
300000
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1300000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3400000
CY2022Q4 dnmr Contract With Customer Asset Current
ContractWithCustomerAssetCurrent
2765000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2021Q4 dnmr Contract With Customer Asset Current
ContractWithCustomerAssetCurrent
2128000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
214000
CY2023Q2 dnmr Contract With Customer Asset Current
ContractWithCustomerAssetCurrent
3703000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2022Q4 dnmr Contract With Customer Asset Current
ContractWithCustomerAssetCurrent
2765000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2023Q2 us-gaap Revenues
Revenues
12865000
CY2022Q2 us-gaap Revenues
Revenues
12703000
us-gaap Revenues
Revenues
24791000
us-gaap Revenues
Revenues
27446000
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
13666000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
14547000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
28609000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
28245000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11844644
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.23
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M15D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
204254
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.58
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4667
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12044231
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.04
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M23D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
852617000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
93633
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11950598
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.02
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M19D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4696184
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.82
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2023Q2 dnmr Share Based Compensation Arrangement By Share Based Payment Award Options Vested Number Of Shares Vested And Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedNumberOfSharesVestedAndExpectedToVest
11950598
CY2023Q2 dnmr Weighted Average Exercise Price Vested And Expected To Vest
WeightedAverageExercisePriceVestedAndExpectedToVest
14.02
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y2M19D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.17
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.77
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
32800000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D
dnmr Royalty Per Share
RoyaltyPerShare
0.05
dnmr Weights Of Pha Sold
WeightsOfPhaSold
500000000
dnmr Decrease Royalty Per Share
DecreaseRoyaltyPerShare
0.025
dnmr Prepaid Royalties Loss On Forfeiture
PrepaidRoyaltiesLossOnForfeiture
500

Files In Submission

Name View Source Status
0000950170-23-039907-index-headers.html Edgar Link pending
0000950170-23-039907-index.html Edgar Link pending
0000950170-23-039907.txt Edgar Link pending
0000950170-23-039907-xbrl.zip Edgar Link pending
dnmr-20230630.htm Edgar Link pending
dnmr-20230630.xsd Edgar Link pending
dnmr-ex10_1.htm Edgar Link pending
dnmr-ex31_1.htm Edgar Link pending
dnmr-ex31_2.htm Edgar Link pending
dnmr-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
dnmr-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dnmr-20230630_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dnmr-20230630_cal.xml Edgar Link unprocessable
dnmr-20230630_def.xml Edgar Link unprocessable
dnmr-20230630_lab.xml Edgar Link unprocessable